AM Biotech’s Unique Bio-pulsed Exosome, Backed by Patents, Shows Bright Prospects in the Global Market

Chairman of AM Biotech, shared the strategic layout of the “bio-pulse induced exosome Technology Platform.”

Chairman of AM Biotech Went to The 49th Annual Meeting of Taiwanese Dermatological Association (TDA) to Give A Special Lecture

Special Lecture at the 2024 Taiwan Dermatology Annual Conference. Discussing the efficiency and mechanism of

Bio-Pulsed Exosome with innovative patented technology from AM Biotech to restore health and beauty

Ascension Medical Biotechnology company(AM Biotech) from Taiwan focusing on the research and development of induced

AM Biotech and Tri-Service General Hospital discussed collaboration matters regarding preclinical research and clinical trials of biochemical pulse extracellular vesicles.

AM Biotech and Tri-Service General Hospital discussed collaboration matters regarding preclinical research and clinical trials

Chairman of AM Biotech delivered a speech at Taiwan Anti-aging and Cells Regeneration Association.

Chairman of AM Biotech delivered a speech at Taiwan Anti-aging and Cells Regeneration Association.

Cosmoprof Asia 2022 – Singapore Special Edition

Cosmoprof Asia, the leading B2B event in Asia-Pacific for all sectors of the beauty industry,

The Key to Skin Repair: The Fantastic Bio-Pulsed Exosomes

Ascension Medical Biotechnology Co., Ltd. (abbreviation: AM BioTech) is the first in Taiwan and the

2022 Asia Healthcare & Medical Cosmetology Expo

We participated in 2022 Asia Healthcare & Medical Cosmetology Expo. Welcome to contact us! Date:2022/7/28-2022/7/31

The Emergent Role of Exosome Therapy in 2021

Exosomes are extracellular vesicles (EV) derived from endosomes, ranging in size from 30nm to 150nm.